Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Stille ABOSTO:STIL -1.80%98 Return-on-Tangible-Asset is 15.92% as of Mar. 2026, which is 24% above its 10-year median of 12.87. GuruFocus rates OSTO:STIL with a GF Score™ of 98/100 and a GF Value™ of kr238.16 (Fairly Valued). The stock has 2 warning signs investors should review. Among 856 Medical Devices & Instruments companies, Stille AB ranks better than 88.32% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Stille AB's annualizedNet Income for the quarter that ended in Mar. 2026 was kr83.7 Mil. Stille AB's average total tangible assets for the quarter that ended in Mar. 2026 was kr525.5 Mil. Therefore, Stille AB's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 15.92%.
The historical rank and industry rank for Stille AB's Return-on-Tangible-Asset or its related term are showing as below:
OSTO:STIL'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 5.95 Med: 12.87 Max: 24.49
Current: 12.32
During the past 13 years, Stille AB's highest Return-on-Tangible-Asset was 24.49%. The lowest was 5.95%. And the median was 12.87%.
OSTO:STIL's Return-on-Tangible-Asset is ranked better than 88.32% of 856
companies
in the Medical Devices & Instruments industry
Industry Median: 0.665
vs OSTO:STIL: 12.32
Stille AB (OSTO:STIL) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Stille AB Return-on-Tangible-Asset Related Terms
Stille AB Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Stille AB's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:STIL vs ISRG, BDX, MDLN: Return-on-Tangible-Asset Comparison
For the Medical Instruments & Supplies subindustry, Stille AB's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stille AB Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stille AB's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Stille AB's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 15.92% mean?
Stille AB (OSTO:STIL) has a Return-on-Tangible-Asset of 15.92% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Stille AB and its competitors. This is 24% above median its historical median of 12.87. Over the past decade, Stille AB's Return-on-Tangible-Asset has ranged from 5.95 to 24.49. According to the industry distribution chart, Stille AB ranks #100 out of 856 companies in the Medical Devices & Instruments industry, placing it in the top 11.7%.
Is Stille AB's Return-on-Tangible-Asset too high?
Stille AB's current Return-on-Tangible-Asset of 15.92% is 24% above median its 10-year median of 12.87. Over the past 10 years, this metric has ranged from a low of 5.95 to a high of 24.49. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.67. Stille AB's value of 15.92% is 2294% above this industry median. Based on the distribution chart, Stille AB ranks #100 out of 856 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Stille AB has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Stille AB's Return-on-Tangible-Asset compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Stille AB ranks #100 out of 856 companies for Return-on-Tangible-Asset. This places Stille AB in the top 12% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 0.67. Stille AB's value of 15.92% is 2294% above this benchmark. Historically, Stille AB's own Return-on-Tangible-Asset has ranged from 5.95 to 24.49 over the past decade. While the company's 10-year median is 12.87 vs. the industry median of 0.67, Stille AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.67, based on 856 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Stille AB's current Return-on-Tangible-Asset of 15.92% is 2294% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Stille AB and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stille AB's current Return-on-Tangible-Asset is 15.92%, which is 24% above median its own 10-year median of 12.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stille AB stock overvalued right now?
Based on GuruFocus' analysis, Stille AB (OSTO:STIL) is currently considered Fairly Valued. The stock's GF Value™ is kr238.16, compared to a current price of kr245.50 — trading 3.1% above its estimated fair value. The current Return-on-Tangible-Asset is 15.92%, which is 24% above median its 10-year median of 12.87 and 2294% above the Medical Devices & Instruments industry median of 0.67. Stille AB's overall GF Score™ is 98/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Stille AB (OSTO:STIL), the current Return-on-Tangible-Asset is 15.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stille AB (OSTO:STIL) Overvalued in 2026?
Based on GuruFocus' analysis, Stille AB stock appears to be overvalued.
The current stock price of kr245.50 is trading 3.1% above its estimated GF Value™ of kr238.16.
GuruFocus considers Stille AB to be Fairly Valued.
Key valuation signals for OSTO:STIL:
Return-on-Tangible-Asset: 15.92% (24% above median its 10-year median of 12.87)
GF Value™: kr238.16 vs. price of kr245.50 (3.1% above fair value)
Industry Position: 2294% above the Medical Devices & Instruments median (#100 of 856)
No single metric tells the full story. See the OSTO:STIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stille AB manufactures and distributes medical devices. Its products include surgical equipment such as Surgical Scissors, Forceps, Curettes, Raspatories, Elevators, c-arm tables and instrument care education, among others.
98GF Score
Get the complete analysis for OSTO:STIL
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:STIL has been successfully added to your 
